TruSight Oncology 500 High Throughput Reference Guide
The TruSight Oncology 500 High Throughput (HT) protocol describes an enrichment-based approach to convert DNA and RNA extracted from formalin-fixed paraffin embedded (FFPE) tissue samples into libraries enriched for cancer-related genes that can be sequenced on Illumina sequencing systems. The kit is optimized to provide high sensitivity and specificity for low-frequency somatic variants across 523 genes, detecting single nucleotide variants, insertions, deletions, gene amplifications, multinucleotide variants, and immunotherapy biomarkers for tumor mutational burden and microsatellite instability in DNA. Fusions and splice variants are detected in RNA.
| Minimum DNA input | 40 ng |
|---|---|
| Minimum RNA input | 80 ng |
| Optimal fragment size | 90-250 bp |
| Recommended sonication instruments | Covaris E220evolution, LE220, or ME220 |
| Recommended DNA QC method | Illumina FFPE QC Kit |
| Recommended RNA QC method | Advanced Analytical Technologies Fragment Analyzer or Agilent Technologies 2100 Bioanalyzer |
| Recommended DNA QC threshold | delta Cq value < 5 |
| Recommended RNA QC threshold | DV200 value of 20% |
The minimum DNA input required is 40 ng.
The minimum RNA input required is 80 ng.
The assay is optimized to prepare libraries from gDNA that are fragmented to 90-250 bp.